Kuo WH - Search Results

1

Combating breast cancer progression through combination therapy with hypomethylating agent and glucocorticoid.

Chu YH, Huang YC, Chiu PY, Kuo WH, Pan YR, Kuo YT, Wang RH, Kao YC, Wang YH, Lin YF, Lin KT. Chu YH, et al. Among authors: kuo wh. iScience. 2023 Apr 8;26(5):106597. doi: 10.1016/j.isci.2023.106597. eCollection 2023 May 19. iScience. 2023. PMID: 37128608 Free PMC article.

2

Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.

Chang JW, Kuo WH, Lin CM, Chen WL, Chan SH, Chiu MF, Chang IS, Jiang SS, Tsai FY, Chen CH, Huang PH, Chang KJ, Lin KT, Lin SC, Wang MY, Uen YH, Tu CW, Hou MF, Tsai SF, Shen CY, Tung SL, Wang LH. Chang JW, et al. Among authors: kuo wh. Oncogene. 2018 Jul;37(30):4137-4150. doi: 10.1038/s41388-018-0253-9. Epub 2018 Apr 30. Oncogene. 2018. PMID: 29706651 Free PMC article.

3

Monocytes secrete CXCL7 to promote breast cancer progression.

Wang YH, Shen CY, Lin SC, Kuo WH, Kuo YT, Hsu YL, Wang WC, Lin KT, Wang LH. Wang YH, et al. Among authors: kuo wh, kuo yt. Cell Death Dis. 2021 Nov 17;12(12):1090. doi: 10.1038/s41419-021-04231-4. Cell Death Dis. 2021. PMID: 34789744 Free PMC article.

4

Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway.

Tseng CW, Kuo WH, Chan SH, Chan HL, Chang KJ, Wang LH. Tseng CW, et al. Among authors: kuo wh. Cancer Res. 2018 Jun 1;78(11):2799-2812. doi: 10.1158/0008-5472.CAN-17-2906. Epub 2018 Mar 29. Cancer Res. 2018. PMID: 29599405

5

Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple-Negative Breast Cancer.

Chan SH, Tsai KW, Chiu SY, Kuo WH, Chen HY, Jiang SS, Chang KJ, Hung WC, Wang LH. Chan SH, et al. Among authors: kuo wh. Mol Cancer Ther. 2019 Jan;18(1):147-161. doi: 10.1158/1535-7163.MCT-18-0292. Epub 2018 Oct 31. Mol Cancer Ther. 2019. PMID: 30381446

6

Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer Stem Cells.

Yu WH, Wu E, Li Y, Hou HH, Yu SC, Huang PT, Kuo WH, Qi D, Yu CJ. Yu WH, et al. Among authors: kuo wh. iScience. 2020 Sep 23;23(10):101600. doi: 10.1016/j.isci.2020.101600. eCollection 2020 Oct 23. iScience. 2020. PMID: 33089100 Free PMC article.

7

Vascularity change and tumor response to neoadjuvant chemotherapy for advanced breast cancer.

Kuo WH, Chen CN, Hsieh FJ, Shyu MK, Chang LY, Lee PH, Liu LY, Cheng CH, Wang J, Chang KJ. Kuo WH, et al. Ultrasound Med Biol. 2008 Jun;34(6):857-66. doi: 10.1016/j.ultrasmedbio.2007.11.011. Epub 2008 Mar 28. Ultrasound Med Biol. 2008. PMID: 18374468

8

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.

Kuo WH, Chang YY, Lai LC, Tsai MH, Hsiao CK, Chang KJ, Chuang EY. Kuo WH, et al. PLoS One. 2012;7(9):e45831. doi: 10.1371/journal.pone.0045831. Epub 2012 Sep 25. PLoS One. 2012. PMID: 23049873 Free PMC article.

9

Upregulation of LGALS1 is associated with oral cancer metastasis.

Li JM, Tseng CW, Lin CC, Law CH, Chien YA, Kuo WH, Chou HC, Wang WC, Chan HL. Li JM, et al. Among authors: kuo wh. Ther Adv Med Oncol. 2018 Aug 24;10:1758835918794622. doi: 10.1177/1758835918794622. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 30159048 Free PMC article.

10

Role of PGRMC1 in cell physiology of cervical cancer.

Shih CC, Chou HC, Chen YJ, Kuo WH, Chan CH, Lin YC, Liao EC, Chang SJ, Chan HL. Shih CC, et al. Among authors: kuo wh. Life Sci. 2019 Aug 15;231:116541. doi: 10.1016/j.lfs.2019.06.016. Epub 2019 Jun 16. Life Sci. 2019. PMID: 31216441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

290 results

Search Page